Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,184 | -4,510 | -331,942 | -274,558 | 4,986 |
| Depreciation Amortization | 12,622 | 5,803 | 28,684 | 23,671 | 13,212 |
| Income taxes - deferred | N/A | N/A | 76,201 | 47,192 | -1,385 |
| Accounts receivable | 7,750 | 5,054 | 48,669 | 33,865 | 3,749 |
| Other Working Capital | 4,288 | 3,580 | 140 | -2,190 | -862 |
| Other Operating Activity | -1,581 | -2,419 | 227,852 | 215,917 | 21,618 |
| Operating Cash Flow | $14,895 | $7,508 | $49,604 | $43,897 | $41,318 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,320 | N/A | N/A | 0 | N/A |
| PPE Investments | N/A | N/A | -628 | -528 | -528 |
| Net Acquisitions | N/A | N/A | 1,531 | 1,670 | -280 |
| Sale Of Investment | N/A | N/A | 2,194 | 2,194 | N/A |
| Investing Cash Flow | $-43,320 | $N/A | $3,097 | $3,336 | $-808 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -10,500 | -10,500 | -10,500 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 157 |
| Other Financing Activity | -281 | -206 | -33,701 | -24,786 | -24,933 |
| Financing Cash Flow | $-281 | $-206 | $-44,201 | $-35,286 | $-35,276 |
| Beginning Cash Position | 73,441 | 73,441 | 64,941 | 64,941 | 64,941 |
| End Cash Position | 44,735 | 80,743 | 73,441 | 76,888 | 70,175 |
| Net Cash Flow | $-28,706 | $7,302 | $8,500 | $11,947 | $5,234 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,895 | 7,508 | 49,604 | 43,897 | 41,318 |
| Capital Expenditure | N/A | N/A | -628 | -528 | -528 |
| Free Cash Flow | 14,895 | 7,508 | 48,976 | 43,369 | 40,790 |